Effect of Surface Interactions on Microsphere Loading in Dissolving Microneedle Patches
Source abstract
Abstract
Microneedle (MN) patches enable simple self-administration of drugs via the skin. In this study, we sought to deliver drug-loaded microspheres (MSs) using MN patches and found that the poly(lactic-co-glycolic acid) (PLGA) MSs failed to localize in the MN tips during fabrication, thereby decreasing their delivered dose and delivery efficiency into skin. We determined that surface interactions between the hydrophobic MSs and the poly(dimethylsiloxane) (PDMS) mold caused MSs to adhere to the mold surface during casting in aqueous formulations, with hydrophobic interactions largely responsible for adhesion. Further studies with polystyrene MSs that similarly carry a negative charge like the PLGA MSs demonstrated both repulsive electrostatic interactions as well as adhesive hydrophobic interactions. Reducing hydrophobic interactions by addition of a surfactant or modifying mold surface properties increased MS loading into MN tips and delivery into porcine skin ex vivo by 3-fold. We conclude that surface interactions affect the loading of hydrophobic MSs into MN patches during aqueous fabrication procedures and that their modulation with the surfactant can increase loading and delivery efficiency.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Ocular Surface and Contact Lens
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48109, United States
School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
Funding
Bill and Melinda Gates Foundation
References (50)
Show source-provided references
1. Fuhrman L. · 2006 · 70 · 71
2. 10.1021/cr940351u10.1021/cr940351u ↗
3. 10.1038/s41578-021-00405-w10.1038/s41578-021-00405-w ↗
4. 10.1007/978-1-4614-0881-910.1007/978-1-4614-0881-9 ↗
5. 10.1615/CritRevTherDrugCarrierSyst.201300647510.1615/CritRevTherDrugCarrierSyst.2013006475 ↗
6. 10.1016/j.actbio.2018.04.00610.1016/j.actbio.2018.04.006 ↗
7. 10.1002/1520-6017(200012)89:12<1558::AID-JPS6>3.0.CO;2-810.1002/1520-6017(200012)89:12<1558::AID-JPS6>3.0.CO;2-8 ↗
8. Simonsen L. · Bull. W. H. O. · 1999 · 77 · 789
9. 10.1146/annurev-chembioeng-060816-10151410.1146/annurev-chembioeng-060816-101514 ↗
10. 10.1016/j.jconrel.2017.02.01110.1016/j.jconrel.2017.02.011 ↗
11. 10.1016/j.biopha.2018.10.07810.1016/j.biopha.2018.10.078 ↗
12. 10.1021/js980042+10.1021/js980042+ ↗
13. 10.1016/j.apsb.2019.03.00710.1016/j.apsb.2019.03.007 ↗
14. 10.3390/pharmaceutics1206056910.3390/pharmaceutics12060569 ↗
15. 10.1007/s40005-021-00512-410.1007/s40005-021-00512-4 ↗
16. 10.1016/j.addr.2012.04.00510.1016/j.addr.2012.04.005 ↗
17. 10.1007/s11095-006-0028-910.1007/s11095-006-0028-9 ↗
18. 10.1038/s41551-018-0337-410.1038/s41551-018-0337-4 ↗
19. 10.1016/j.biomaterials.2012.12.04110.1016/j.biomaterials.2012.12.041 ↗
20. 10.1016/j.jconrel.2019.10.02210.1016/j.jconrel.2019.10.022 ↗
21. 10.1021/acsabm.0c0067110.1021/acsabm.0c00671 ↗
22. 10.1016/j.xphs.2020.02.00910.1016/j.xphs.2020.02.009 ↗
23. 10.1016/j.jconrel.2017.10.00510.1016/j.jconrel.2017.10.005 ↗
24. 10.3389/fbioe.2019.0029610.3389/fbioe.2019.00296 ↗
25. 10.1016/j.biomaterials.2012.03.05610.1016/j.biomaterials.2012.03.056 ↗
26. 10.1002/adfm.20120151210.1002/adfm.201201512 ↗
27. 10.1002/btm2.1010310.1002/btm2.10103 ↗
28. Sully, E. A.; Biddlecom, A.; Darroch, J. E.; Riley, T.; Ashford, L. S.; Lince-Deroche, N.; Firestein, L.; Murro, R.Adding It Up: Investing in Sexual and Reproductive Health 2019. 2020.10.1363/2020.31593 ↗
29. 10.1001/jama.2021.2139210.1001/jama.2021.21392 ↗
30. 10.1016/j.eclinm.2022.10127310.1016/j.eclinm.2022.101273 ↗
31. 10.1002/adma.20070120510.1002/adma.200701205 ↗
32. 10.1016/j.biomaterials.2007.12.04810.1016/j.biomaterials.2007.12.048 ↗
33. 10.1007/s13346-018-00593-z10.1007/s13346-018-00593-z ↗
34. Israelachvili, J. N. Intermolecular and Surface Forces; Academic Press, 2011; pp 253–380.10.1016/B978-0-12-391927-4.10013-1 ↗
35. 10.1515/epoly.2009.9.1.11010.1515/epoly.2009.9.1.110 ↗
36. 10.1002/jps.2161210.1002/jps.21612 ↗
37. 10.1063/1.324391310.1063/1.3243913 ↗
38. 10.2494/photopolymer.24.59710.2494/photopolymer.24.597 ↗
39. 10.1088/0960-1317/22/2/02501210.1088/0960-1317/22/2/025012 ↗
40. 10.1038/s41598-019-43625-510.1038/s41598-019-43625-5 ↗
41. Cospheric. Tween Biocompatible Surfactants. 2020.
42. 10.1002/jps.2214010.1002/jps.22140 ↗
43. 10.1073/pnas.080513510510.1073/pnas.0805135105 ↗
44. 10.1016/j.scitotenv.2018.02.29610.1016/j.scitotenv.2018.02.296 ↗
45. 10.1116/6.000061110.1116/6.0000611 ↗
46. 10.1016/0927-7757(94)02985-710.1016/0927-7757(94)02985-7 ↗
47. 10.1016/j.ijpharm.2018.05.02510.1016/j.ijpharm.2018.05.025 ↗
48. 10.1126/sciadv.abb659410.1126/sciadv.abb6594 ↗
49. Therapeutics, F. ZILRETTA Prescribing Information, 2017.
50. 10.1109/TBME.2006.88917310.1109/TBME.2006.889173 ↗